A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

NCT ID: NCT02219490

Last Updated: 2023-04-07

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

1596 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-10-30

Study Completion Date

2021-05-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to evaluate the effect of treatment with ABT-450 co-formulated with ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333; 3-DAA regimen, with or without ribavirin (RBV) in adults with chronic hepatitis C virus genotype 1 (HCV GT1) infection.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study (TOPAZ-I; M14-423), was a Phase 3b, open-label, multicenter study conducted outside of the United States which, together with its companion study TOPAZ-II (M14-222; NCT 02167945) conducted in the United States, was designed with the primary objective of assessing the effect of treatment response on long-term clinical outcomes in adults with chronic HCV GT1 infection with or without compensated cirrhosis, who were either treatment-naïve or interferon/ribavirin (IFN/RBV) treatment- experienced. In both studies, participants were treated with the 3-DAA regimen with or without RBV. This study consisted of a screening period of up to 42 days, a treatment period of either 12 weeks for HCV GT1a-infected subjects without cirrhosis and for HCV GT1b-infected subjects without cirrhosis or with compensated cirrhosis or 24 weeks for GT1a-infected participants with compensated cirrhosis, and a 260-week post-treatment period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Hepatitis C Virus (HCV) Infection Genotype 1

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ABT-450/r/ABT-267 plus ABT-333 with or without ribavirin (RBV)

Participants with HCV GT1b without cirrhosis received the 3-DAA (ABT-450/ritonavir/ABT-267 and ABT-333) regimen: two 75 mg ABT-450/50 mg ritonavir/12.5 mg ABT-267 tablets taken orally every morning (QD) and one ABT-333 250 mg tablet taken orally twice a day (BID) for 12 weeks. Participants with HCV GT1a without cirrhosis and those with HCV GT1b with cirrhosis received the 3-DAA regimen and weight-based ribavirin (RBV; 1000 to 1200 mg divided twice daily per local label) for 12 weeks. Participants with HCV GT1a with cirrhosis received the 3-DAA regimen and weight-based RBV per local label for 24 weeks.

Group Type EXPERIMENTAL

ABT-450/r/ABT-267

Intervention Type DRUG

Tablet for oral use

ABT-333

Intervention Type DRUG

Tablet for oral use

Ribavirin (RBV)

Intervention Type DRUG

Ribavirin was provided as 200 mg tablets, and dosed based on weight,1000 to 1200 mg divided twice daily per local label. For example, for participants weighing \< 75 kg, RBV may have been taken orally as 2 tablets in the morning and 3 tablets in the evening which corresponds to a 1000 mg total daily dose. For participants weighing ≥ 75 kg, RBV may have been taken orally as 3 tablets in the morning and 3 tablets in the evening which corresponds to a 1200 mg total daily dose.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ABT-450/r/ABT-267

Tablet for oral use

Intervention Type DRUG

ABT-333

Tablet for oral use

Intervention Type DRUG

Ribavirin (RBV)

Ribavirin was provided as 200 mg tablets, and dosed based on weight,1000 to 1200 mg divided twice daily per local label. For example, for participants weighing \< 75 kg, RBV may have been taken orally as 2 tablets in the morning and 3 tablets in the evening which corresponds to a 1000 mg total daily dose. For participants weighing ≥ 75 kg, RBV may have been taken orally as 3 tablets in the morning and 3 tablets in the evening which corresponds to a 1200 mg total daily dose.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ABT-450 also known as paritaprevir ABT-267 also known as ombitasvir Paritaprevir/ritonavir/ombitasvir also known as Viekirax ABT-333 also known as dasabuvir ABT-333 also known as Exviera

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Males and females at least 18 years old at screening
2. Females must be post-menopausal for more than 2 years or surgically sterile or practicing acceptable forms of birth control
3. Chronic hepatitis C, genotype 1 infection
4. Males must be surgically sterile or agree to practice acceptable forms of birth control
5. Screening laboratory result indicating HCV genotype 1 infection

Exclusion Criteria

1. Use of contraindicated medications within 2 weeks of dosing
2. Abnormal laboratory tests
3. Current or past clinical evidence of Child-Pugh B or C classification or history of liver decompensation
4. Confirmed presence of hepatocellular carcinoma
5. History of solid organ transplant
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AbbVie

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

ABBVIE INC.

Role: STUDY_DIRECTOR

AbbVie

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Bab El Oued /ID# 145420

Algiers, , Algeria

Site Status

CHU Bologhine Hospital /ID# 145421

Algiers, , Algeria

Site Status

CHU Mustapha Bacha /ID# 132130

Algiers, , Algeria

Site Status

St Vincent's Hospital Sydney /ID# 131001

Darlinghurst, New South Wales, Australia

Site Status

Nepean Hospital /ID# 130999

Kingswood, New South Wales, Australia

Site Status

Westmead Hospital /ID# 130997

Westmead, New South Wales, Australia

Site Status

Greenslopes Private Hospital /ID# 131003

Greenslopes, Queensland, Australia

Site Status

Royal Brisbane and Women's Hospital /ID# 131004

Herston, Queensland, Australia

Site Status

Royal Adelaide Hospital /ID# 131002

Adelaide, South Australia, Australia

Site Status

St Vincent's Hospital Melbourne /ID# 131000

Fitzroy Melbourne, Victoria, Australia

Site Status

The Royal Melbourne Hospital /ID# 130998

Parkville, Victoria, Australia

Site Status

Medizinische Universitaet Graz /ID# 131018

Graz, Styria, Austria

Site Status

Ordensklinikum Linz GmbH Elisabethinen /ID# 131017

Linz, Upper Austria, Austria

Site Status

Medizinische Universitaet Wien /ID# 131015

Vienna, Vienna, Austria

Site Status

Cliniques Universitaires de Bruxelles Hopital Erasme /ID# 131020

Brussels, Brussels Capital, Belgium

Site Status

UCL Saint-Luc /ID# 131019

Woluwe-Saint-Lambert, Brussels Capital, Belgium

Site Status

Universitair Ziekenhuis Leuven /ID# 131021

Leuven, Vlaams-Brabant, Belgium

Site Status

Tokuda Hospital Sofia /ID# 131022

Sofia, , Bulgaria

Site Status

UMHAT Sveti Ivan Rilski /ID# 131026

Sofia, , Bulgaria

Site Status

Univ Hosp for Active Treat /ID# 131023

Sofia, , Bulgaria

Site Status

Diagnostic Consultative Center /ID# 131027

Sofia, , Bulgaria

Site Status

UMHAT Sveta Marina /ID# 131025

Varna, , Bulgaria

Site Status

University of Calgary /ID# 134370

Calgary, Alberta, Canada

Site Status

GI Research & Associates /ID# 132169

Edmonton, Alberta, Canada

Site Status

LAIR Centre /ID# 130970

Vancouver, British Columbia, Canada

Site Status

Vancouver Infectious Diseases Centre /ID# 134369

Vancouver, British Columbia, Canada

Site Status

GIRI Gastrointestinal Research Institute /ID# 132171

Vancouver, British Columbia, Canada

Site Status

University of Manitoba / Health Scuience Centre / John Buhler Research Centre /ID# 130969

Winnipeg, Manitoba, Canada

Site Status

Saint John Regional Hospital /ID# 131210

Saint John, New Brunswick, Canada

Site Status

Ottawa Hospital Research Institute /ID# 132170

Ottawa, Ontario, Canada

Site Status

Toronto General Hospital /ID# 132134

Toronto, Ontario, Canada

Site Status

Toronto Liver Centre /ID# 132168

Toronto, Ontario, Canada

Site Status

Toronto Digestive Disease Asso /ID# 130968

Vaughan, Ontario, Canada

Site Status

Clinique Medicale L'Actuel /ID# 132167

Montreal, Quebec, Canada

Site Status

Jewish General Hospital /ID# 132165

Montreal, Quebec, Canada

Site Status

Royal Victoria Hospital / McGill University Health Centre /ID# 132166

Montreal, Quebec, Canada

Site Status

CHU de Quebec-Université Laval hôpital CHUL /ID# 132132

Québec, Quebec, Canada

Site Status

Kobenhavns Universitet - Hvidovre Hospital (HH) /ID# 131031

Hvidovre, Capital Region, Denmark

Site Status

Odense University Hospital /ID# 131029

Odense C, Region Syddanmark, Denmark

Site Status

Aarhus Univ Hospital, Skejby /ID# 131030

Aarhus, , Denmark

Site Status

Helsinki University Hospital /ID# 131034

Helsinki, Uusimaa, Finland

Site Status

Turku University Hospital /ID# 131032

Turku, , Finland

Site Status

Hopital Saint Joseph /ID# 132177

Marseille, Bouches-du-Rhone, France

Site Status

CHU Limoges - Dupuytren 1 /ID# 131038

Limoges, Franche-Comte, France

Site Status

Hopital Haut-Lévêque /ID# 131036

Pessac, Gironde, France

Site Status

Hopital Saint Eloi /ID# 131037

Montpellier, Herault, France

Site Status

CHU de Nantes, Hotel Dieu -HME /ID# 132179

Nantes, Pays de la Loire Region, France

Site Status

Hopital Jean Verdier /ID# 135877

Bondy, , France

Site Status

CHU Grenoble - Hopital Michallon /ID# 131041

La Tronche, , France

Site Status

HCL - Hopital de la Croix-Rousse /ID# 131042

Lyon, , France

Site Status

Duplicate_Hopital lArchet 2 /ID# 131040

Nice, , France

Site Status

CHRU Pontchaillou /ID# 132173

Rennes, , France

Site Status

CHU Strasbourg - Hopital Civil /ID# 132174

Strasbourg, , France

Site Status

Hopital Universitaire Purpan Hopital Rangueil /ID# 131035

Toulouse, , France

Site Status

Universitaetsklinikum Freiburg /ID# 131044

Freiburg im Breisgau, Baden-Wurttemberg, Germany

Site Status

Universitaetsklinik Heidelberg /ID# 134371

Heidelberg, Baden-Wurttemberg, Germany

Site Status

Universitaetsklinikum Tuebingen Medizinische Klinik /ID# 131045

Tübingen, Baden-Wurttemberg, Germany

Site Status

LMU Klinikum der Universitat Muchen /ID# 131049

Munich, Bavaria, Germany

Site Status

Universitaetsklinikum Frankfurt /ID# 131055

Frankfurt am Main, Hesse, Germany

Site Status

Zentru fur HIV und Heaptogastroenterologie /ID# 131052

Düsseldorf, North Rhine-Westphalia, Germany

Site Status

Gastroenterologische Gemeinschaftspraxis Herne /ID# 131050

Herne, North Rhine-Westphalia, Germany

Site Status

Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie /ID# 131053

Berlin, , Germany

Site Status

Universitaetsklinikum Essen /ID# 131048

Essen, , Germany

Site Status

Universitaetsklinikum Hamburg-Eppendorf (UKE) /ID# 131051

Hamburg, , Germany

Site Status

Medizinische Hochschule Hannover /ID# 131054

Hanover, , Germany

Site Status

Centrum für interdisziplinaere Medizin /ID# 131046

Münster, , Germany

Site Status

General Hospital of Athens Ippokratio /ID# 131057

Athens, Attica, Greece

Site Status

General Hospital of Athens Laiko /ID# 131088

Athens, Attica, Greece

Site Status

General University Hospital of Alexandroupolis /ID# 131056

Alexandroupoli, , Greece

Site Status

Beaumont Hospital /ID# 131089

Beaumont, Dublin, Ireland

Site Status

St James Hospital /ID# 132180

Dublin, Dublin, Ireland

Site Status

St Vincent's University Hospital /ID# 132181

Elm Park, Dublin, Ireland

Site Status

The Chaim Sheba Medical Center /ID# 131092

Ramat Gan, Tel Aviv, Israel

Site Status

Tel Aviv Sourasky Medical Center /ID# 132182

Tel Aviv, Tel Aviv, Israel

Site Status

Rambam Health Care Campus /ID# 131090

Haifa, , Israel

Site Status

The Lady Davis Carmel Medical Center /ID# 131091

Haifa, , Israel

Site Status

Duplicate_A.O.U. Policlinico S.Orsola-Malpighi /ID# 131095

Bologna, Emilia-Romagna, Italy

Site Status

Azienda Ospedaliero-Universitaria di Ferrara-Arcispedale Sant Anna /ID# 131102

Cona, Ferrara, Italy

Site Status

Fondazione di Religione e di Culto Casa Sollievo della Sofferenza /ID# 132190

San Giovanni Rotondo, Foggia, Italy

Site Status

Policlinico Agostino Gemelli /ID# 131098

Rome, Lazio, Italy

Site Status

Ospedale San Raffaele IRCCS /ID# 131093

Milan, Lombardy, Italy

Site Status

Fondazione PTV Policlinico Tor Vergata /ID# 132185

Rome, Roma, Italy

Site Status

Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII (Presidio Papa Giovanni /ID# 132188

Bergamo, , Italy

Site Status

Azienda Ospedaliero Universitaria Careggi /ID# 132197

Florence, , Italy

Site Status

Azienda Ospedaliera Universitaria Ospedali Riuniti /ID# 132195

Foggia, , Italy

Site Status

A.O.U. Policlinico G. Martino /ID# 132193

Messina, , Italy

Site Status

Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico /ID# 131097

Milan, , Italy

Site Status

Ospedale S Giuseppe /ID# 132194

Milan, , Italy

Site Status

ASST Santi Paolo e Carlo/Presidio Ospedale San Paolo /ID# 132198

Milan, , Italy

Site Status

ASST Fatebenefratelli Sacco-Ospedale Sacco /ID# 134372

Milan, , Italy

Site Status

Azienda Ospedaliera Niguarda Ca' Granda Hospital /ID# 131104

Milan, , Italy

Site Status

Azienda Ospedaliera Universitaria Federico II /ID# 131096

Napoli, , Italy

Site Status

Azienda Ospedaliera Universitaria Federico II /ID# 132191

Napoli, , Italy

Site Status

Azienda Ospedaliera Universitaria Paolo Giaccone /ID# 132184

Palermo, , Italy

Site Status

Azienda Ospedaliero-Universitaria di Parma /ID# 132183

Parma, , Italy

Site Status

Azienda Ospedaliera Universitaria "San Giovanni di Dio e Ruggi d'Aragona /ID# 132192

Salerno, , Italy

Site Status

A.O.U. Citta della Salute e della Scienza di Torino /ID# 131100

Turin, , Italy

Site Status

Azienda Ospedaliera Universitaria Friuli Centrale/Presidio Ospedaliero Universit /ID# 132196

Udine, , Italy

Site Status

Hospital General de Tijuana /ID# 130972

Tijuana, Estado de Baja California, Mexico

Site Status

Cife /Id# 130974

Guadalajara, Jalisco, Mexico

Site Status

Instituto Nacional de Clencias Medicas y Nutricion Salvador Zubrian Departament /ID# 130975

Distrito Federal, , Mexico

Site Status

CIF-BIOTEC/Medica Sur /ID# 134971

Mexico City, , Mexico

Site Status

ITESM campus Ciudad de Mexico /ID# 132383

Mexico City, , Mexico

Site Status

Instituto Metropolitano de Inv /ID# 132201

Tlalpan, , Mexico

Site Status

Erasmus Medisch Centrum /ID# 132206

Rotterdam, South Holland, Netherlands

Site Status

Academisch Medisch Centrum /ID# 132205

Amsterdam, , Netherlands

Site Status

Leids Universitair Medisch Centrum /ID# 132204

Leiden, , Netherlands

Site Status

Akershus Universitetssykehus_MAIN /ID# 132212

Lorenskog, Akershus, Norway

Site Status

St. Olavs Hospital HF /ID# 132213

Trondheim, Sor-Trondelag, Norway

Site Status

Stavanger University Hospital /ID# 132211

Stavanger, , Norway

Site Status

Wojewodzki Szpital Obserwacyjno-Zakazny im. Tadeusza Browicza /ID# 131106

Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

Site Status

Samodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie /ID# 131115

Lublin, Lublin Voivodeship, Poland

Site Status

Wojewodzki Szpital Zakazny /ID# 131112

Warsaw, Masovian Voivodeship, Poland

Site Status

Uniwersytecki Szpital Kliniczny w Bialymstoku /ID# 131108

Bialystok, Podlaskie Voivodeship, Poland

Site Status

ID Clinic /ID# 131111

Mysłowice, Silesian Voivodeship, Poland

Site Status

Wojewodzki Specjalistyczny Szpital im. dr. W. Bieganskiego /ID# 131107

Lodz, Łódź Voivodeship, Poland

Site Status

Centro Hospitalar e Universitario de Coimbra, EPE /ID# 131119

Coimbra, , Portugal

Site Status

Centro Hospitalar Universitario Lisboa Central, EPE - Hospital dos Capuchos /ID# 131116

Lisbon, , Portugal

Site Status

Centro Hospitalar Universitário de Lisboa Norte, EPE - Hospital de Santa Maria /ID# 131118

Lisbon, , Portugal

Site Status

Centro Hospitalar Universitário do Porto, EPE - Hospital Santo António /ID# 131117

Porto, , Portugal

Site Status

Duplicate_Institutul National de Boli Infectioase Prof. Dr. Matei Bals /ID# 131120

Sector 2, București, Romania

Site Status

Institutul Clinic Fundeni /ID# 131121

Sector 2, București, Romania

Site Status

Spitalul Clinic de Boli Infectioase Si Pneumoftiziologie Dr. Victor Babes /Id# 131126

Timișoara, Timiș County, Romania

Site Status

Institutul Nat. de Boli Infectioase /ID# 131124

Bucharest, , Romania

Site Status

SC Gastromedica SRL /ID# 131127

Iași, , Romania

Site Status

Medical Company Hepatolog /ID# 132277

Samara, Samara Oblast, Russia

Site Status

Republican Clinical Infectious Diseases Hospital n.a. Professor A. F. Agafonov /ID# 132270

Kazan', Tatarstan, Respublika, Russia

Site Status

South-Ural State Med. Academy /ID# 132274

Chelyabinsk, , Russia

Site Status

Kuzbass Center for Prevention and Fight agains AIDS /ID# 132269

Kemerovo, , Russia

Site Status

Krasnoyarsk Regional Center for the Prevention and Control of AIDS /ID# 132278

Krasnoyarsk, , Russia

Site Status

Moscow Clinical Scientific Center n.a. Loginov /ID# 132266

Moscow, , Russia

Site Status

Central Clinical Hospital of Russian Academy of Science /ID# 132289

Moscow, , Russia

Site Status

I. M. Sechenov First Moscow State Medical University /ID# 132275

Moscow, , Russia

Site Status

City Clinical Hospital #24 /ID# 132268

Moscow, , Russia

Site Status

Research Institute of Emergency Medicine named after V.I. N.V. Sklifosovsky /ID# 132288

Moscow, , Russia

Site Status

Clinical Infectious Diseases Hospital #1 /ID# 132272

Novosibirsk, , Russia

Site Status

Samara State Medical University /ID# 136913

Samara, , Russia

Site Status

Stavropol State Medical University /ID# 132279

Stavropol, , Russia

Site Status

Tolyatti City Clinical Hospital #1 /ID# 132273

Tolyatti, , Russia

Site Status

Multidisciplinary Consultative and Diagnostic Center /ID# 131130

Tyumen, , Russia

Site Status

Sverdlovsk Regional Clinical Hospital #1 /ID# 132267

Yekaterinburg, , Russia

Site Status

King Abdulaziz Medical City /ID# 145129

Jeddah, , Saudi Arabia

Site Status

Ministry Nat Guard Hosp Health /ID# 145126

Riyadh, , Saudi Arabia

Site Status

King Khalid University Hospita /ID# 132291

Riyadh, , Saudi Arabia

Site Status

Hospital Universitari Son Espases /ID# 131140

Palma de Mallorca, Balearic Islands, Spain

Site Status

Hospital Universitario Germans Trias i Pujol /ID# 132293

Badalona, Barcelona, Spain

Site Status

Hospital Unversitario Marques de Valdecilla /ID# 131141

Santander, Cantabria, Spain

Site Status

Hospital Donostia /ID# 131144

Donostia / San Sebastian, Guipuzcoa, Spain

Site Status

Hospital General Universitario Santa Lucia /ID# 131139

Cartagena, Murcia, Spain

Site Status

Hospital Universitario Central de Asturias /ID# 131138

Oviedo, Principality of Asturias, Spain

Site Status

OSI Ezkerraldea-Enkarterri-Cruces /ID# 131143

Barakaldo, Vizcaya, Spain

Site Status

Hospital Universitario A Coruna - CHUAC /ID# 131137

A Coruña, , Spain

Site Status

Hospital Universitario Reina Sofia /ID# 131135

Córdoba, , Spain

Site Status

Hospital Universitario de la Princesa /ID# 131131

Madrid, , Spain

Site Status

Hospital Universitario 12 de Octubre /ID# 131133

Madrid, , Spain

Site Status

Hospital Universitario La Paz /ID# 131132

Madrid, , Spain

Site Status

Hospital Universitario Virgen de la Victoria /ID# 131136

Málaga, , Spain

Site Status

Hospital Universitario Virgen del Rocio /ID# 131134

Seville, , Spain

Site Status

Hospital Clinico Universitario Lozano Blesa /ID# 132292

Zaragoza, , Spain

Site Status

Skane University hospital /ID# 131146

Malmo, Skåne County, Sweden

Site Status

Karolinska University Hospital Solna /ID# 131145

Solna, Stockholm County, Sweden

Site Status

Sahlgrenska University Hospital /ID# 131147

Gothenburg, Västra Götaland County, Sweden

Site Status

Kantonsspital St. Gallen /ID# 131148

Sankt Gallen, Canton of St. Gallen, Switzerland

Site Status

Universitätsspital Zürich /ID# 134881

Zurich, Canton of Zurich, Switzerland

Site Status

Inselspital, Universitätsspital Bern /ID# 132294

Bern, , Switzerland

Site Status

Izmir Tepecik Training and Research Hospital /ID# 134968

Konak, İzmir, Turkey (Türkiye)

Site Status

Hacettepe University Faculty of Medicine /ID# 131150

Ankara, , Turkey (Türkiye)

Site Status

Ankara Univ Medical Faculty /ID# 131151

Ankara, , Turkey (Türkiye)

Site Status

Uludag University Medical Faculty /ID# 132297

Bursa, , Turkey (Türkiye)

Site Status

Istanbul University Istanbul Medical Faculty /ID# 131153

Istanbul, , Turkey (Türkiye)

Site Status

Ege University Medical Faculty /ID# 132298

Izmir, , Turkey (Türkiye)

Site Status

Karadeniz University /ID# 131152

Trabzon, , Turkey (Türkiye)

Site Status

Duplicate_University Hospitals Dorset NHS Foundation Trust /ID# 132306

Poole, Dorset, United Kingdom

Site Status

University Hospital Southampton NHS Foundation Trust /ID# 131161

Southampton, Hampshire, United Kingdom

Site Status

Barts Health NHS Trust /ID# 132302

London, London, City of, United Kingdom

Site Status

The Royal Free London NHS Foundation Trust /ID# 131159

London, London, City of, United Kingdom

Site Status

Duplicate_Nottingham University Nottingham University Hospitals NHS Trust /ID# 131155

Nottingham, Nottinghamshire, United Kingdom

Site Status

NHS Greater Glasgow and Clyde /ID# 131162

Glasgow, Scotland, United Kingdom

Site Status

University Hospitals Birmingham NHS Foundation Trust /ID# 131154

Birmingham, , United Kingdom

Site Status

Duplicate_NHS Tayside /ID# 132300

Dundee, , United Kingdom

Site Status

NHS Lothian /ID# 134368

Edinburgh, , United Kingdom

Site Status

Leeds Teaching Hospitals NHS Trust /ID# 132305

Leeds, , United Kingdom

Site Status

King's College Hospital NHS Foundation Trusts /ID# 131157

London, , United Kingdom

Site Status

University Hospital Plymouth NHS Trust /ID# 131160

Plymouth, , United Kingdom

Site Status

Portsmouth Hospitals University NHS Trust /ID# 131158

Portsmouth, , United Kingdom

Site Status

Northern Care Alliance NHS Group /ID# 131156

Salford, , United Kingdom

Site Status

St George's University Hospitals NHS Foundation Trust /ID# 132301

Tooting, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Algeria Australia Austria Belgium Bulgaria Canada Denmark Finland France Germany Greece Ireland Israel Italy Mexico Netherlands Norway Poland Portugal Romania Russia Saudi Arabia Spain Sweden Switzerland Turkey (Türkiye) United Kingdom

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2014-001022-14

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

M14-423

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.